Skip to content

Public FDA record

Z-1795-2026: BRAHMS KRYPTOR compact REACT, REF: 89986, used with BRAHMS PlGF Plus KRYPTOR, REF: 859075N, and run on th

Recall record Z-1795-2026 for Brahms GmbH. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1795-2026
Company in FDA record
Brahms GmbH
FDA classification date
Apr 8, 2026
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Customers have observed quality control values out of range at the lowest quality control level (QC Level 1) for the PIGF assay which require troubleshooting steps to resolve. If Quality Controls are not performed according to the Instructions for Use, the underestimation of QC1 may go undetected and could contribute to falsely elevated sFlt-1/PlGF ratio results. A falsely elevated sFlt-1/PlGF ratio may result in a higher-risk classification for progression to preeclampsia with severe features potentially leading to intensified clinical monitoring.

Source facts

Action
On 2/27/2026, correction notices were sent to customers informing them: 1. Continue to perform Quality Control testing in accordance with the current Instructions for Use prior to reporting patient results. 2. If Quality Control results fall outside plus-minus 20% of target values follow the troubleshooting procedures described in the User Manual. 3. Forward this letter to those who need to be aware within your organization or to any organization to whom the potentially affected devices have been transferred. Keep this notification on file. For further questions, please contact the firm's customer service on 1-800-232-3342 or e-mail to: USFMTMGC-TechnicalService@thermo.com On 3/12/2026, Follow-up notices were sent to customers who were informed the root cause had been identified, which identified reaction plate affected devices. Customers were asked to do the following: 1) Stop using and dispose affected reaction plates. 2) Complete and return the response form. 3) Same as point 3 above.
Initiated
2026-03-12
Root cause
Under Investigation by firm
Distribution
Worldwide distribution. US states: NC, TX, MN, UT, NY, FL, OH, IL, CT, CA, GA. Other countries: DE, AT, AL, AU, BG, BR, CA, CH, CZ, DK, EC, ET, ES, FR, GB, GR, HK, HU, ID, IL, IT, KW, KZ, LT, MK, ML, MX, NL, NO, PA, PL, PT, RO, RS, SE, SI, TH, TU, TW, UA, ZA
Recall number
Z-1795-2026
Recall status
Open, Classified
CDRH record ID
219084
FDA classified
2026-04-08
Recall event number
98561

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗